Benevolentai
Business Services · United Kingdom · 201-500 Employees
View Company Info for Free
Overview
Headquarters
4-8 Maple St, London, Greater London, W1...Phone Number
+44 2030960720Website
www.benevolent.comRevenue
$25.4 MillionStock Symbol
2XA.FIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Benevolentai
BenevolentAI's mission is to use AI and machine learning to improve drug discovery and development. The amount of available data is overwhelming, and despite a steady stream of new research, too many pharmaceutical experiments fail today. BenevolentAI helps by accelerating the indexing and retrieval of medical papers and clinical trial reports about new treatments for diseases that don't have cures. Fact-based decision-making is essential everywhere, but for the pharmaceutical industry, the facts just need to be harvested in a synthetic, relevant, and efficient way.Explore more
Benevolentai Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Benevolentai your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Benevolentai had a recent Job posting/layoffs
Product Launch: Get notified when Benevolentai launches new products
Congratulate Masked Content for being promoted to Masked Content at Benevolentai
Earning: See what the market has to say on Benevolentai recently announced quarterly report
Check out if Benevolentai is spiking on competitors!
Funding: Get notified immidiatlly once Benevolentai has new funding data
Check if Benevolentai has recently received funding, and reach out quickly before it becomes old news!
Benevolentai, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Benevolentai
Find more new buyers
Compare Similar Companies to Benevolentai
Compare insights from companies similar to Benevolentai, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Benevolentai is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Benevolentai is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Benevolentai.
Benevolentai financials insights
Gather financial insights about Benevolentai, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Other Financing Round
$115M
Benevolentai Tech Stack
A closer look at the technologies used by Benevolentai
Most Recent Scoops
Layoffs
Layoffs, Financial Planning, Financial Strategy
Executive Move
Executive Moves, Board of Directors
Executive Move
Executive Moves, Board of Directors
Left Company
Executive Move
Executive Moves, Left Company
Executive Move
Executive Moves, Board of Directors
Benevolentai News & Media
Less than a year in, BenevolentAI CEO is out—Chutes & Ladders - Fierce Biotech
Welcome to this week's Chutes & Ladders, our roundup | It’s been a whirlwind year for Joerg Moeller, M.D. After being appointed CEO of BenevolentAI in January, Moeller is now out the door of the AI drug discoverer, effective immediately.BenevolentAI lays off 30% of staff, exits US site as funding gap looms - Fierce Biotech
The cuts keep coming at BenevolentAI. | The cuts keep coming at BenevolentAI. Eleven months after restructuring, the AI-enabled drug developer is pulling another pivot, axing plans to launch software products, laying off another 30% of staff and closing its U.S. office.BenevolentAI appoints former Bayer R&D chief as CEO | BioPharma Dive
The pharma veteran will take over the AI-focused biotech after a year that included a restructuring, job cuts and the resignation of its CFO.BenevolentAI taps former Bayer R&D chief to help steer the AI biotech out of choppy waters
Last year was rocky for a number of the first AI-based biotechs that entered the clinic, including BenevolentAI. | BenevolentAI has named longtime pharma exec Joerg Moeller as its new CEO. He previously led R&D at LEO Pharma after nearly two decades at Bayer.
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Benevolentai
Sign Up For FreeTo access detailed company insights
BenevolentAI's mission is to use AI and machine learning to improve drug discovery and development. The amount of available data is overwhelming, and despite a steady stream of new research, too many pharmaceutical experiments fail today. BenevolentAI helps by accelerating the indexing and retrieval of medical papers and clinical trial reports abou... Read More
